Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 222

The DOI matches its Crossref record.

S100A12 is a novel molecular marker differentiating systemic‐onset juvenile idiopathic arthritis from other causes of fever of unknown origin

Open access
Wittkowski, Helmut, Frosch, Michael, Wulffraat, Nico, Goldbach‐Mansky, Raphaela, Kallinich, Tilmann, Kuemmerle‐Deschner, Jasmin, Frühwald, Michael C., Dassmann, Sandra, Pham, Tuyet‐Hang, Roth, Johannes, Foell, Dirk·2008·Arthritis & Rheumatism

Abstract

Objective: Fever of unknown origin (FUO) in children presents a diagnostic challenge. The differential diagnosis includes systemic‐onset juvenile idiopathic arthritis (JIA), an autoinflammatory syndrome associated with activation of phagocytic cells that, at presentation, is difficult to differentiate from severe systemic infections. The aim of this study was to investigate whether serum concentrations of the phagocytic proinflammatory protein S100A12 may help in deciding whether to treat patients with FUO with antibiotics or immunosuppressive agents. Methods: Serum samples were obtained from 45 healthy control subjects and from 240 patients (60 with systemic‐onset JIA, 17 with familial Mediterranean fever [FMF], 18 with neonatal‐onset multisystem inflammatory disease [NOMID], 17 with Muckle‐Wells syndrome [MWS], 40 with acute lymphoblastic leukemia [ALL], 5 with acute myeloblastic leukemia [AML], and 83 with systemic infections). All samples were collected at the time of presentation, before the initiation of any treatment, and concentrations of S100A12 were determined by enzyme‐linked immunosorbent assay. Results: The mean ± 95% confidence interval serum levels of S100A12 were as follows: in patients with JIA, 7,190 ± 2,690 ng/ml; in patients with FMF, 6,720 ± 4,960 ng/ml; in patients with NOMID, 720 ± 450 ng/ml; in patients with MWS, 150 ± 60 ng/ml; in patients with infections, 470 ± 160 ng/ml; in patients with ALL, 130 ± 80 ng/ml; in patients with AML, 45 ± 60 ng/ml; in healthy control subjects, 50 ± 10 ng/ml. The sensitivity and specificity of S100A12 to distinguish between systemic‐onset JIA and infections were 66% and 94%, respectively. Conclusion: S100A12, a marker of granulocyte activation, is highly overexpressed in patients with systemic‐onset JIA or FMF, which may point to as‐yet unknown common inflammatory mechanisms in these diseases. The measurement of S100A12 serum levels may provide a valuable diagnostic tool in the evaluation of FUO.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.24137

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 222

Metadata

Authors
Wittkowski, H., Frosch, M., Wulffraat, N., Goldbach‐Mansky, R., Kallinich, T., Kuemmerle‐Deschner, J., Frühwald, M. C., Dassmann, S., Pham, T., Roth, J., & Foell, D.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2008-11-26
Volume
58
Issue
12
Pages
3924-3931
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W1995428027
Cited by
222
References
0
FWCI
4.96
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: S100A12 is a novel molecular marker differentiating systemic‐onset juvenile idiopathic arthritis from other causes of fever of unknown origin. https://app.cochat.ai/papers/10.1002/art.24137
The paper
Wittkowski, H., Frosch, M., Wulffraat, N., Goldbach‐Mansky, R., Kallinich, T., Kuemmerle‐Deschner, J., Frühwald, M. C., Dassmann, S., Pham, T., Roth, J., & Foell, D. (2008). S100A12 is a novel molecular marker differentiating systemic‐onset juvenile idiopathic arthritis from other causes of fever of unknown origin. Arthritis & Rheumatism. https://doi.org/10.1002/art.24137

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.